Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BIO-11006 by BioMarck Pharmaceuticals for Ewing Sarcoma: Likelihood of Approval
BIO-11006 is under clinical development by BioMarck Pharmaceuticals and currently in Phase II for Ewing Sarcoma. According to GlobalData, Phase...
Data Insights
BIO-11006 by BioMarck Pharmaceuticals for Osteosarcoma: Likelihood of Approval
BIO-11006 is under clinical development by BioMarck Pharmaceuticals and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II...